Loading this company
Lupin Limited
LUPIN.NSPrices in INR
TickerWorth ScoreA72/100
What we think
Priced within our range of ₹877.63 to ₹3,546.15.
Price
₹1,939.20INR down −₹22.40 (−1.14%)
Quoted · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-19 13:20 UTC (5 hours ago).
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 3 models, on today’s numbers
₹877.63–₹3,546.15
What the price needs: revenue growth of 2.7%/yr for 5 years (our model assumes 16.6%).
Led by discounted cash flow (DCF) · Steady cash-flow business
Price ₹1,939.20Priced · Prices are delayed.
Is it a good business?
- Valuation83 out of 100
- Growth83 out of 100
- Financial health100 out of 100
- Dividend75 out of 100
- Past performance75 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
₹2,446.14 across 36 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It operates in the Drug Manufacturers - Specialty & Generic industry (Healthcare sector), headquartered in India. The company employs roughly 26,021 people.
Key stats
52-week range₹1,900.00–₹2,529.50
- Open
- ₹1,955.80
- Day high
- ₹1,971.60
- Day low
- ₹1,930.00
- Previous close
- ₹1,961.60
- Volume
- 601,910 · 0.70× avg
- Average volume
- 865,406
- Market cap
- ₹886,776,725,504.00
- P/E (TTM)
- 16.06
- Earnings per share
- ₹120.73
- Beta
- 0.17
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
No filings or corporate activity on file in the recent window.
Top news
No recent headlines we can cite for this company.
Insider trades
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.